期刊文献+

复方甘草甜素片联合盐酸西替利嗪治疗慢性特发性荨麻疹的疗效观察 被引量:3

Clinical observation of Treating Chronic Urticaria by Stronger Neo-Minophagen C Combined with Cetirizine Hydrochloride Tablets
暂未订购
导出
摘要 目的观察复方甘草甜素片联合盐酸西替利嗪治疗慢性特发性荨麻疹的疗效。方法将110例慢性特发性荨麻疹患者分为两组,治疗组68例口服复方甘草甜素片75 mg,3次/d,盐酸西替利嗪10 mg,1次/d,对照组48例口服盐酸西替利嗪10 mg,1次/d。两组疗程均为4周,均于治疗后第14,30天复诊。结果14天时两组疗效比较,治疗组有效率50.00%,对照组有效率31.25%,两组有效率无显著性差异(χ2=1.24,P>0.05);30天时两组疗效比较,治疗组有效率82.26%,对照组有效率58.33%,两组有效率差异有显著性(χ2=7.65,P<0.01)。结论复方甘草甜素片联合盐酸西替利嗪治疗慢性特发性荨麻疹,疗效满意,值得在临床上应用。 Objective To Study on the treatment result of Chronic urticaria by Stronger Neo-Minophagen C combined with Cetirizine Hydrochloride Tablets. Methods 110 Chronic urticaria patients were divided randomly into two groups, one was control group and the other was treatment group. The patients of treatment group took orally Stronger Neo-Minophagen C three times a day and 75rag per time,and also took orally Cetirizine Hydrochloride Tablets 10 mg one time a day. Patients of control group only took orally Cetirizine Hydrochloride Tablets 10 mg one time a day. The treatment period were 4 weeks and the treatment results were checked before treatment,14 days after treatment,and 30 days after treatment. Results After 14 days the difference between two groups was not significant (χ^2 = 1.24,P 〉 0.05 ). After 30 days the difference between two groups was significant (χ^2= 7.65, P 〈 0.01 ). Conclusion Treatment result of Chronic urticaria by Stronger Neo-Minophagen C combined with Cetirizine Hydrochloride Tabtets is significant, and worth to apply to clinical use.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2006年第3期189-190,共2页 The Chinese Journal of Dermatovenereology
关键词 复方甘草甜素片 盐酸西替利嗪 荨麻疹 Stronger Neo-Minophagen C Cetirizine hydrochloride tablets Urticaria
  • 相关文献

参考文献3

  • 1Negro-Alvarez JM,Mirallers-Lopez JC.Chronic idiopathic urticaria treatment[J].Allergd.Immu nopathol,2001,29 (4):129 -132.
  • 2Ring J,Hein R,Gauger A.Desloradine in the treatment of chronic idiopathic urticaria[J].Allegy,2001,56(65):28-32.
  • 3郝飞.甘草酸国外研究进展[J].中国药房,2001,12(8):500-501. 被引量:108

二级参考文献10

  • 1[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
  • 2[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
  • 3[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double-blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
  • 4[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
  • 5[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
  • 6[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
  • 7[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
  • 8[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.
  • 9[9]Tsabota A. Corrbinecl ursodeoxycholic acid and glycyrrhizin therapy forchronic hepatitis C virus infection:a randomized controlled trial in 170patients[J].Eur J Gastroenterd Hepatol, 1999, 11(10):1 077.
  • 10[10]Shiota G, Harada K, Ishida M, et al. Inhibition of hepatocellularcarcinoma by glycyrrhizin in diethylnitrosa-mine-treated mice[J]. Carcinogenesis, 1999,20(1):59.

共引文献107

同被引文献39

引证文献3

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部